Recent Studies in Brain Imaging for Neurocognitive Disorders

Dear Colleagues,

The management of people suffering from adult age neurocognitive impairment would likely be more successful if imminent brain pathology could be revealed at an early stage when only mild clinical symptoms were present. A great deal of hope in this regard is placed on multimodal neuroimaging. A growing amount of data is indicating that the accumulation of harmful macromolecules, the altered profiles of endogenous neurochemicals, changes in tissue microstructure, small volume and shape changes in critical brain structures, to mention a few, as revealed by advanced imaging techniques, are linked to pathology prior to cognitive impairment. The spatially specific imaging techniques used in the investigation of these issues range from computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and positron emission tomography (PET) to near-infrared spectroscopy (NIRS). The use of automated data processing methods in conjunction with artificial intelligence (AI) has greatly improved precision to detect minor abnormalities in brain images.  

This upcoming edition of the Journal of Clinical Medicine (JCM) invites the submission of both review and original papers for consideration for inclusion in the upcoming Special Issue, entitled ‘Recent Studies on Brain Imaging of Neurocognitive Diseases’. The objective of the Special Issue is to collate timely articles from multimodal brain imaging research on Neurocognitive Disorders, including aging of subjects with increased risk of cognitive impairment, early diagnosis of neurodegenerative diseases by imaging, and the use of imaging in monitoring, management, and treatment of people with neurocognitive disorders. Case studies on clinical neurocognitive disorders using advanced imaging are welcome. Papers will be subjected to standard peer review during editorial processing. 

Prof. Dr. Risto A. Kauppinen
Dr. Claudia Metzler-Baddeley
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• ageing
• cognitive impairment
• dementia
• computed tomography
• magnetic resonance imaging
• magnetic resonance spectroscopy
• positron emission tomography
• near-infrared spectroscopy